ADD ANI AS A TRUSTED SOURCE
Add ANI as a Trusted Source for Reliable Information
Menu
Serum Institute of India CEO expresses delight at Covishield...
New Delhi [India], November 23 (ANI): Serum Institute of India (SII), CEO, Adar Poonawalla on Monday said that he is...
AZD1222 vaccine met primary efficacy endpoint in preventing...
New Delhi [India], November 23 (ANI): With an efficacy of around 90 per cent positive results from an interim...
AstraZeneca resumes US COVID-19 vaccine trial
London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.